The role of BRAF V600 mutation in melanoma

BRAF is a serine/threonine protein kinase activating the MAP kinase/ERK-signaling pathway. About 50 % of melanomas harbors activating BRAF mutations (over 90 % V600E). BRAFV600E has been implicated in different mechanisms underlying melanomagenesis, most of which due to the deregulated activation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ascierto, Paolo A, Kirkwood, John M, Grob, Jean-Jacques, Simeone, Ester, Grimaldi, Antonio M, Maio, Michele, Palmieri, Giuseppe, Testori, Alessandro, Marincola, Francesco M, Mozzillo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391993/
https://www.ncbi.nlm.nih.gov/pubmed/22554099
http://dx.doi.org/10.1186/1479-5876-10-85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3391993/
https://www.ncbi.nlm.nih.gov/pubmed/22554099
http://dx.doi.org/10.1186/1479-5876-10-85

Ejemplares similares